{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:12:05Z","timestamp":1781413925465,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000321","name":"World Cancer Research Fund","doi-asserted-by":"publisher","award":["IIG_FULL_2023_011"],"award-info":[{"award-number":["IIG_FULL_2023_011"]}],"id":[{"id":"10.13039\/501100000321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"name":"Western Australian Future Health Research and Innovation Fund,Governement of Western Australia,Australia","award":["WANMA\/Ideas2023-24\/10"],"award-info":[{"award-number":["WANMA\/Ideas2023-24\/10"]}]},{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","award":["1228"],"award-info":[{"award-number":["1228"]}],"id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13555-9","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:40:50Z","timestamp":1738057250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exercise medicine as adjunct therapy during RADIation for CAncer of the prostaTE to improve treatment efficacy \u2013 protocol for the ERADICATE study: a phase II randomised controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Oliver","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert U.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd B.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny S.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Taaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"7","key":"13555_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409\u201325.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"13555_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ctrv.2008.01.006","volume":"34","author":"L Marignol","year":"2008","unstructured":"Marignol L, Coffey M, Lawler M, Hollywood D. Hypoxia in prostate cancer: a powerful shield against tumour destruction? Cancer Treat Rev. 2008;34(4):313\u201327.","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"13555_CR3","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","volume":"18","author":"M Milosevic","year":"2012","unstructured":"Milosevic M, Warde P, M\u00e9nard C, Chung P, Toi A, Ishkanian A, et al. Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer. Clin Cancer Res. 2012;18(7):2108\u201314.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"13555_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1464-410X.2009.08921.x","volume":"105","author":"GD Stewart","year":"2010","unstructured":"Stewart GD, Ross JA, McLaren DB, Parker CC, Habib FK, Riddick AC. The relevance of a hypoxic tumour microenvironment in prostate cancer. BJU Int. 2010;105(1):8\u201313.","journal-title":"BJU Int"},{"issue":"4","key":"13555_CR5","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1470-2045(08)70076-7","volume":"9","author":"R Vergis","year":"2008","unstructured":"Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M, et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. Lancet Oncol. 2008;9(4):342\u201351.","journal-title":"Lancet Oncol"},{"issue":"15","key":"13555_CR6","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1200\/JCO.2002.01.086","volume":"20","author":"JJ Coen","year":"2002","unstructured":"Coen JJ, Zietman AL, Thakral H, Shipley WU. Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases. J Clin Oncol. 2002;20(15):3199\u2013205.","journal-title":"J Clin Oncol"},{"issue":"19","key":"13555_CR7","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1093\/jnci\/djm135","volume":"99","author":"O Tr\u00e9dan","year":"2007","unstructured":"Tr\u00e9dan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007;99(19):1441\u201354.","journal-title":"J Natl Cancer Inst"},{"issue":"6801","key":"13555_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249\u201357.","journal-title":"Nature"},{"issue":"1","key":"13555_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57\u201370.","journal-title":"Cell"},{"issue":"1093","key":"13555_CR10","first-page":"20170955","volume":"92","author":"VS Hughes","year":"2019","unstructured":"Hughes VS, Wiggins JM, Siemann DW. Tumor oxygenation and cancer therapy\u2013then and now. Br J Radiol. 2019;92(1093):20170955.","journal-title":"Br J Radiol"},{"issue":"2 Suppl 8","key":"13555_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0093-7754(01)90210-6","volume":"28","author":"P Vaupel","year":"2001","unstructured":"Vaupel P, Kelleher DK, H\u00f6ckel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol. 2001;28(2 Suppl 8):29\u201335.","journal-title":"Semin Oncol"},{"issue":"1","key":"13555_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41391-020-0245-z","volume":"24","author":"O Schumacher","year":"2021","unstructured":"Schumacher O, Galv\u00e3o DA, Taaffe DR, Chee R, Spry N, Newton RU. Exercise modulation of tumour perfusion and hypoxia to improve radiotherapy response in prostate cancer. Prostate Cancer Prostatic Dis. 2021;24(1):1\u201314.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"13555_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1152\/japplphysiol.00266.2016","volume":"121","author":"E Garcia","year":"2016","unstructured":"Garcia E, Becker VG, McCullough DJ, Stabley JN, Gittemeier EM, Opoku-Acheampong AB, et al. Blood flow responses to mild-intensity exercise in ectopic vs. orthotopic prostate tumors; dependence upon host tissue hemodynamics and vascular reactivity. J Appl Physiol. 2016;121(1):15\u201324.","journal-title":"J Appl Physiol"},{"issue":"4","key":"13555_CR14","doi-asserted-by":"publisher","first-page":"dju036","DOI":"10.1093\/jnci\/dju036","volume":"106","author":"DJ McCullough","year":"2014","unstructured":"McCullough DJ, Stabley JN, Siemann DW, Behnke BJ. Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise. J Natl Cancer Inst. 2014;106(4):dju036.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"13555_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1152\/japplphysiol.01575.2011","volume":"113","author":"LW Jones","year":"2012","unstructured":"Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol. 2012;113(2):263\u201372.","journal-title":"J Appl Physiol"},{"issue":"12","key":"13555_CR16","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1152\/japplphysiol.00949.2013","volume":"115","author":"DJ McCullough","year":"2013","unstructured":"McCullough DJ, Nguyen LM, Siemann DW, Behnke BJ. Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J Appl Physiol. 2013;115(12):1846\u201354.","journal-title":"J Appl Physiol"},{"issue":"3","key":"13555_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"key":"13555_CR18","unstructured":"Sealed Envelope Ltd. Create a blocked randomisation list. https:\/\/www.sealedenvelope.com\/simple-randomiser\/v1\/lists. Accessed 11 Apr 2024."},{"key":"13555_CR19","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.","journal-title":"J Biomed Inf"},{"issue":"2","key":"13555_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381.","journal-title":"J Biomed Inf"},{"issue":"5","key":"13555_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","volume":"14","author":"GA Borg","year":"1982","unstructured":"Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377\u201381.","journal-title":"Med Sci Sports Exerc"},{"key":"13555_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.radonc.2022.06.011","volume":"173","author":"C Onal","year":"2022","unstructured":"Onal C, Erbay G, Guler OC, Oymak E. The prognostic value of mean apparent diffusion coefficient measured with diffusion-weighted magnetic resonance image in patients with prostate cancer treated with definitive radiotherapy. Radiother Oncol. 2022;173:285\u201391.","journal-title":"Radiother Oncol"},{"issue":"1043","key":"13555_CR23","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140359","volume":"87","author":"L Liu","year":"2014","unstructured":"Liu L, Wu N, Ouyang H, Dai JR, Wang WH. Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. Br J Radiol. 2014;87(1043): 20140359.","journal-title":"Br J Radiol"},{"issue":"1","key":"13555_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.radonc.2014.07.016","volume":"113","author":"G Decker","year":"2014","unstructured":"Decker G, M\u00fcrtz P, Gieseke J, Tr\u00e4ber F, Block W, Sprinkart AM, et al. Intensity-modulated radiotherapy of the prostate: dynamic ADC monitoring by DWI at 3.0 T. Radiother Oncol. 2014;113(1):115\u201320.","journal-title":"Radiother Oncol"},{"issue":"2","key":"13555_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ijrobp.2011.06.2009","volume":"83","author":"SY Park","year":"2012","unstructured":"Park SY, Kim CK, Park BK, Park W, Park HC, Han DH, et al. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012;83(2):749\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"13555_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/mrm.10709","volume":"51","author":"P Martirosian","year":"2004","unstructured":"Martirosian P, Klose U, Mader I, Schick F. FAIR true-FISP perfusion imaging of the kidneys. Magn Reson Med. 2004;51(2):353\u201361.","journal-title":"Magn Reson Med"},{"key":"13555_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mri.2021.04.010","volume":"80","author":"M Boschheidgen","year":"2021","unstructured":"Boschheidgen M, Schimm\u00f6ller L, Kasprowski L, Abrar D, Arsov C, Albers P, et al. Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer. Magn Reson Imaging. 2021;80:33\u20138.","journal-title":"Magn Reson Imaging"},{"issue":"4","key":"13555_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/RLI.0000000000000115","volume":"50","author":"E Panagiotaki","year":"2015","unstructured":"Panagiotaki E, Chan RW, Dikaios N, Ahmed HU, O\u2019Callaghan J, Freeman A, et al. Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging. Invest Radiol. 2015;50(4):218\u201327.","journal-title":"Invest Radiol"},{"issue":"3","key":"13555_CR29","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1148\/radiol.212536","volume":"305","author":"S Singh","year":"2022","unstructured":"Singh S, Rogers H, Kanber B, Clemente J, Pye H, Johnston EW, et al. Avoiding unnecessary biopsy after multiparametric prostate MRI with VERDICT analysis: the INNOVATE study. Radiology. 2022;305(3):623\u201330.","journal-title":"Radiology"},{"issue":"12","key":"13555_CR30","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1249\/01.mss.0000233803.48691.8b","volume":"38","author":"DA Galv\u00e3o","year":"2006","unstructured":"Galv\u00e3o DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc. 2006;38(12):2045\u201352.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"13555_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S. The timed up & go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"13555_CR32","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1464-410X.2008.07539.x","volume":"102","author":"DA Galv\u00e3o","year":"2008","unstructured":"Galv\u00e3o DA, Spry NA, Taaffe DR, Newton RU, Stanley J, Shannon T, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008;102(1):44\u20137.","journal-title":"BJU Int"},{"issue":"6","key":"13555_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"5","key":"13555_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/S0022-5347(17)36966-5","volume":"148","author":"MJ Barry","year":"1992","unstructured":"Barry MJ, Fowler FJ Jr, O\u2019Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549\u201357.","journal-title":"J Urol"},{"issue":"6","key":"13555_CR35","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899\u2013905.","journal-title":"Urology"},{"issue":"2","key":"13555_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D, Lai JS, Chang CH, Peterman A, Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94(2):528\u201338.","journal-title":"Cancer"},{"issue":"2","key":"13555_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF 3, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213.","journal-title":"Psychiatry Res"},{"issue":"2","key":"13555_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1249\/MSS.0000000000002127","volume":"52","author":"CM Fairman","year":"2020","unstructured":"Fairman CM, Nilsen TS, Newton RU, Taaffe DR, Spry N, Joseph D, et al. Reporting of resistance training dose, adherence, and tolerance in exercise oncology. Med Sci Sports Exerc. 2020;52(2):315\u201322.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"13555_CR39","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1249\/MSS.0000000000001545","volume":"50","author":"TS Nilsen","year":"2018","unstructured":"Nilsen TS, Scott JM, Michalski M, Capaci C, Thomas S, Herndon JE 2, et al. Novel methods for reporting of exercise dose and adherence: an exploratory analysis. Med Sci Sports Exerc. 2018;50(6):1134\u201341.","journal-title":"Med Sci Sports Exerc"},{"issue":"8","key":"13555_CR40","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"key":"13555_CR41","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE). https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm. Accessed 11 Apr 2024."},{"issue":"2","key":"13555_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","volume":"28","author":"DA Galv\u00e3o","year":"2010","unstructured":"Galv\u00e3o DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340\u20137.","journal-title":"J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13555-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13555-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T09:40:58Z","timestamp":1738057258000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13555-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13555"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13555-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study described in this protocol was approved by the Human Research Ethics Committee at Edith Cowan University (reference number: 2023-04149-SCHUMACHER). All participants are required to provide written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}